As concurrent haematological disease such as myelodysplastic syndrome (MDS) may occur with VEXAS, the presence of a somatic UBA1 mutation is now being detected in patients with longstanding diagnoses of MDS pre-existing the discovery of VEXAS [6]. This evidence concerns the gene UBA1 and hematologic disorder.